Causal inference in a placebo-controlled clinical trial with binary outcome and ordered compliance

被引:39
作者
Goetghebeur, E [1 ]
Molenberghs, G [1 ]
机构
[1] LIMBURGS UNIV CTR,BIOSTAT RES UNIT,B-3590 DIEPENBEEK,BELGIUM
关键词
coarsening; counterfactual framework; efficacy; intention to treat; interval censoring; ordinal data;
D O I
10.2307/2291711
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
We propose a likelihood-based method to analyze the causal effect of partial compliance (i.e., unplanned partial exposure to treatment or placebo) in the LRC-CPPT data, a prevention trial with long term follow-up previously analyzed by Efron and Feldman. Initially, we construct ordered compliance categories and dichotomize response. Assuming increased exposure to cholestyramine does not increase cholesterol, we estimate exposure-response curves in different compliance subsets. Subjects in different arms with similar levels of compliance to the assignment may have a different placebo prognosis (i.e., success probability under a possible zero exposure level). The sole assumption that the placebo group reflects response to zero exposure for the treatment group as a whole allows estimation of a causal parameter in a special case only. When a single parameter represents the association between responses to possible treatment exposures and treatment compliance, simple estimates are derived for a set of causal parameters. The example is analyzed in detail, and more general applicability and extensions of the method are discussed.
引用
收藏
页码:928 / 934
页数:7
相关论文
共 18 条
[1]  
Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629
[2]   GLOBAL CROSS-RATIO MODELS FOR BIVARIATE, DISCRETE, ORDERED RESPONSES [J].
DALE, JR .
BIOMETRICS, 1986, 42 (04) :909-917
[3]  
EFRON B, 1991, J AM STAT ASSOC, V86, P9, DOI 10.2307/2289707
[4]  
GOETGHEBEUR E, 1995, STAT MED
[5]  
GOETGHEBEUR EJT, 1993, DRUG INF J, V27, P837
[6]   IGNORABILITY AND COARSE DATA [J].
HEITJAN, DF ;
RUBIN, DB .
ANNALS OF STATISTICS, 1991, 19 (04) :2244-2253
[7]  
HOLLAND PW, 1986, J AM STAT ASSOC, V81, P945, DOI 10.2307/2289064
[8]  
Huang J., 1995, STAT NEERL, V49, P153, DOI DOI 10.1111/J.1467-9574.1995.TB01462.X
[9]   IDENTIFICATION AND ESTIMATION OF LOCAL AVERAGE TREATMENT EFFECTS [J].
IMBENS, GW ;
ANGRIST, JD .
ECONOMETRICA, 1994, 62 (02) :467-475
[10]   ANALYSIS OF CLINICAL-TRIALS BY TREATMENT ACTUALLY RECEIVED - IS IT REALLY AN OPTION [J].
LEE, YJ ;
ELLENBERG, JH ;
HIRTZ, DG ;
NELSON, KB .
STATISTICS IN MEDICINE, 1991, 10 (10) :1595-1605